Davis Morris, MD is a pediatric allergist and division chief of allergy at Dayton Children's Hospital. Dr. Morris was born and raised in the Dayton area. He completed his medical school education at Wright State University Boonshoft School of Medicine in Dayton, Ohio. Following college, he spent his internship and residency in pediatrics at Dayton Children's Hospital. He completed his fellowship in allergy and immunology at Cincinnati Children's Hospital Medical Center in Cincinnati, Ohio. Dr. Morris is board certified in both pediatrics and allergy and immunology. He has participated in multiple peer-reviewed articles and serves as an assistant professor in pediatrics at Wright State University Boonshoft School of Medicine. Dr. Morris was awarded an American Academy of Allergy, Asthma and Immunology Fellow-In-Training Grant in Characterization of Eosinophil Progenitors in the Peripheral Blood of Pediatric Patients with Active Eosinophilic Esophagitis (2014).
When asked why he chose to specialize in pediatric allergy and immunology, he said that it is because of the ever changing knowledge within the field that makes each day exciting. One of his favorite things about working with children is their spirit and resiliency in the face of adversity. Outside of the hospital, Dr. Morris enjoys activities with his children.
schedule an appointment
Scheduling in-person appointments for new patients only. For follow-up, second opinion or video visit appointments, please call 937-641-4000
If your child is an existing patient, log in to MyKidsChart to schedule directly with your provider for follow up care.
important: Please schedule your appointment at least 4 days out to allow time for pausing any medication that may affect your visit. For the full list of medications that should be discontinued click here.
Watch Dr. Morris discuss Spring allergies on Facebook Live:
education and training
medical school: Wright State University Boonshoft School of Medicine, Dayton, Ohio
Rosenberg CE, Mingler MK, Caldwell JM, Collins MH, Fulkerson PC, Morris D, Mukkada VA, Putnam PE, Shoda T, Wen T, Rothenberg, ME; Esophageal IgG4 Levels correlate with histopathic and transcriptomic features in eosinophilic esophagitis, Allergy (2018); 73:1892-1901
Tuttle KL, Schneider TR, Henrickson S, Morris D, Abonia JP, Spergel J, Laidlaw T; Asprin-exacerbrated respiratory disease; not always "adult-onset", JACI: In Practice (2016) Vol. 4 (4) pages 756-758
Morris D, Stucke E, Martin LJ, Abonia JP, Mukkada VA, Putnam PE, Rothenberg ME, Fulkerson P, Eosinophil progenitor levels are increased in active pediatric eosinophilic esophagitis, JACI (2016), 138 (3):915-918
Miller RD, ......Morris D (44 of 63), High-density single-polymorphism maps of the human genome, Genomics (2005) August, 86 (2):117-26.
Berberich SJ, Litteral V, Mayo LD, Tabesh D, Morris D, Mdm-2 Gene Amplification in 3T3L1 Preadipocytes, Differentiation (1999) May 64 (4):205-212.
clinical trial experience
Compassionate Use Open-Label Study of Anti-IL-5 (Mepolizumab) Treatment in Subjects with Hypereosinophilic Syndrome, Sub-Investigator, 2013-2016
ARC: Oral Desnsitization to Peanut in Peanut-Allergic Children and Adults using Characterized Peanut Allergen (CPNA) Peanut Oral Immunotherapy (OIT) Safety Follow-On Study, Sub-Investigator, 2014-present
A Double-Blind, Placebo-Controlled, Randomized Phase III Pivotal Trial to Assess the Efficacy and Safety of Peanut Epicutaneous Immunotherapy with ViaSkin(R) Peanut in Peanut-Allergic Children (PEPITES Study), Sub-Investigator, 2015-2016
MTAX: A Phase 2 Study Multi Oral Immunotherapy in Multi Food allergic Patients to Test Tolerance, Sub-Investigator, 2015-present
REGENERON Protocol R668-EE-1324: A Randomized, Double-Blind, Parallel, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Dupilumab in Adult Patients with Active Eosinophilic Esophagitis, Sub-Investigator, 2015-present
CEGIR 7802: SOFEED Study: Six Food vs One Food Eosinophilic Esophagitis Elimination Diet (SOFEED) followed by Swallowed Glucocorticoid Trial, Sub-Investigator, 2015-present
PCORI diet study: Eosinophilic Esophagitis (EoE) Intervention Trail-Randomized 1 Food Elimination vs. 4 Food Elimination Diet followed by Swallowed Glucocorticoids, Sub Investigators 2015-present